FORR:NASDAQForrester Research, Inc. Analysis

Forrester Research (FORR) is trading at $6.56, hovering just below the computed resistance of $6.87 and above the support at $5.63. The stock’s technical picture is mixed: the 14‑day RSI sits at 56, indicating neutral momentum, while the MACD line remains slightly above its signal, giving a modest bullish bias. Volatility is elevated at roughly 50% over the past 30 days, and a beta of 0.59 suggests the stock moves less than the market, but the recent max drawdown of more than 55% underscores the downside risk. Fundamentals are weaker – revenue fell 4.9% YoY to $85.45 M, operating margin is negative (-6.6%), and trailing EPS is –$2.80, though free cash flow is surprisingly strong at $59.1 M. The balance sheet shows a debt‑to‑equity ratio of about 59%, modest cash of $146 M, and a price‑to‑book near 1.19, indicating limited financial leverage. Analysts’ consensus remains a “hold” with a target price of $6, implying limited upside from the current level. The DCF model, however, values the company at $43.7, translating to an implied upside of more than 500%, but this is likely overstated given the operational challenges.
Given the disconnect between the lofty DCF estimate and the current fundamentals, the stock appears undervalued from a pure valuation standpoint but carries significant execution risk. The lack of a dividend eliminates any income component, and the company’s exposure to global consulting markets introduces medium geographic risk while regulatory risk remains low. Liquidity is constrained, with average daily volume far exceeding today’s thin trading, placing the liquidity risk at a medium level. In the short term, the modest bullish MACD and proximity to support suggest a cautious hold with a conviction of 5, as investors wait for clearer earnings momentum. Over the medium horizon, the combination of a potential turnaround in revenue retention and the large DCF upside supports a hold with a slightly higher conviction of 6. For investors with a longer outlook who believe the firm can reverse its margin erosion, the long‑term thesis tilts toward a buy, reflected by a conviction of 7, anchored on the substantial value gap and the possibility of improved cash generation.